硅光电倍增器PET/CT与传统PET/CT在疑似肺癌患者中的比较:一项试点研究
该单次注射、双机成像试点研究纳入17例疑似肺癌患者,分别用硅光电倍增器(SiPM)PET/CT(含BSREM重建)与传统光电倍增器(PM)PET/CT(含OSEM重建)扫描。疑似恶性原发肿瘤的SUVmax无显著差异,但疑似恶性胸腔内淋巴结的SUVmax在SiPM系统上高10%(p=0.026)。简化TNM分期一致性良好(14/17例),未观察到肺癌检出改善。
要点
- SiPM PET/CT(BSREM)与传统PET/CT(OSEM)在疑似恶性原发肿瘤SUVmax上无显著差异。
- 疑似恶性胸腔内淋巴结SUVmax在SiPM系统上高10%(p=0.026)。
- 简化TNM分期一致性良好(14/17例),未观察到肺癌检出改善。
核心结论
- 在临床环境中,采用BSREM重建的SiPM PET/CT相比PM PET/CT(OSEM)为疑似淋巴结转移提供了更高的SUVmax,但未改善肺癌检出。
研究设计与样本
- 单次注射、双机成像试点研究,纳入17例因疑似肺癌行18F-FDG PET/CT初诊和分期的患者。
- 患者均接受SiPM PET/CT(Discovery MI,GE Healthcare)和PM PET/CT(Discovery 690,GE Healthcare)扫描。
- 比较两系统的SUV和图像解读,并在有组织病理学时进一步比较图像解读与病理结果。
主要发现
- 疑似恶性原发肿瘤的SUVmax在两PET/CT系统间无统计学显著差异。
- 疑似恶性胸腔内淋巴结的SUVmax在SiPM系统上高10%(p=0.026)。
- 简化TNM分期比较显示两系统一致性良好(14/17例)。
- 可获得的组织学结果未发现两系统间有明显差异。
关键数值与推荐
- 疑似恶性胸腔内淋巴结SUVmax在SiPM系统上高10%(p=0.026)。
- 简化TNM分期一致性为14/17例。
临床怎么用
- 对于疑似肺癌患者,SiPM PET/CT(BSREM)可能提高淋巴结转移的SUVmax,但需注意其未显示肺癌检出改善。
局限性
- 试点研究样本量小(17例),结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung cancer is one of the most common cancers in the world. Early detection and correct staging are fundamental for treatment and prognosis. Positron emission tomography with computed tomography (PET/CT) is recommended clinically. Silicon (Si) photomultiplier (PM)-based PET technology and new reconstruction algorithms are hoped to increase the detection of small lesions and enable earlier detection of pathologies including metastatic spread. The aim of this study was to compare the diagnostic performance of a SiPM-based PET/CT (including a new block-sequential regularization expectation maximization (BSREM) reconstruction algorithm) with a conventional PM-based PET/CT including a conventional ordered subset expectation maximization (OSEM) reconstruction algorithm. The focus was patients admitted for 18F-fluorodeoxyglucose (FDG) PET/CT for initial diagnosis and staging of suspected lung cancer. Patients were scanned on both a SiPM-based PET/CT (Discovery MI; GE Healthcare, Milwaukee, MI, USA) and a PM-based PET/CT (Discovery 690; GE Healthcare, Milwaukee, MI, USA). Standardized uptake values (SUV) and image interpretation were compared between the two systems. Image interpretations were further compared with histopathology when available. RESULTS: Seventeen patients referred for suspected lung cancer were included in our single injection, dual imaging study. No statically significant differences in SUVmax of suspected malignant primary tumours were found between the two PET/CT systems. SUVmax in suspected malignant intrathoracic lymph nodes was 10% higher on the SiPM-based system (p = 0.026). Good consistency (14/17 cases) between the PET/CT systems were found when comparing simplified TNM staging. The available histology results did not find any obvious differences between the systems. CONCLUSION: In a clinical setting, the new SiPM-based PET/CT system with a new BSREM reconstruction algorithm provided a higher SUVmax for suspected lymph node metastases compared to the PM-based system. However, no improvement in lung cancer detection was seen.
引用
- Economou Lundeberg J, Oddstig J, Bitzén U, et al. Comparison between silicon photomultiplier-based and conventional PET/CT in patients with suspected lung cancer-a pilot study. EJNMMI Res. 2019. PMID: 31511997. doi:10.1186/s13550-019-0504-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。